NIK Is Involved In the Activation of the Classical and Alternative NF-κB Pathways In Diffuse Large B Cell Lymphoma.

被引：0
|
作者：
Odqvist, Lina [1 ]
Sanchez-Beato, Margarita [1 ]
Montes-Moreno, Santiago [1 ]
Young, Ken H. [2 ]
Acquadro, Francesco [3 ]
Cigudosa, Juan [3 ]
Martinez-Climent, Jose A. [4 ]
Saez, Anabel [5 ]
Sanchez, Lydia [6 ]
Piris, Miguel A. [1 ]
机构：
[1] Spanish Natl Canc Res Ctr, Lymphoma Group, Madrid, Spain
[2] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA
[3] Spanish Natl Canc Res Ctr, Human Canc Genet Programme, Mol Cytogenet Grp, Madrid, Spain
[4] Univ Navarra, Div Oncol, Ctr Appl Med Res, E-31080 Pamplona, Spain
[5] Cecilia Univ Hosp, Tumor Bank Network Andalucia, Granada, Spain
[6] Spanish Natl Canc Res Ctr, Biotechnol Programme, Histol & Immunohistochem Core Unit, Madrid, Spain
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1278 / 1278
页数：1
相关论文
共 50 条
  • [31] β-TrCP1 promotes cell proliferation via TNF-dependent NF-κB activation in diffuse large B cell lymphoma
    Cai, Nannan
    Chen, Zhuolin
    Huang, Yuejiao
    Shao, Shan
    Yu, Haiyan
    Wang, Yuchan
    He, Song
    CANCER BIOLOGY & THERAPY, 2020, 21 (03) : 241 - 247
  • [32] NIK and the Alternative NF-κB Pathway in Human Lymphomas.
    Odqvist, Lina
    Sanchez-Beato, Margarita
    Montes-Moreno, Santiago
    Gomez-Abad, Cristina
    Sanchez, Lydia
    Rodriguez-Lopez, Ana
    Angel Martinez-Climent, Jose
    Martinez-Lopez, Joaquin
    Javier Alves, Francisco
    Piris, Miguel A.
    BLOOD, 2009, 114 (22) : 1516 - 1516
  • [33] Chromosome instability in diffuse large B cell lymphomas is suppressed by activation of the noncanonical NF-κB pathway
    Ramachandiran, Sampath
    Adon, Arsene
    Guo, Xiangxue
    Wang, Yi
    Wang, Huichen
    Chen, Zhengjia
    Kowalski, Jeanne
    Sunay, Ustun R.
    Young, Andrew N.
    Brown, Theresa
    Mar, Jessica C.
    Du, Yuhong
    Fu, Haian
    Mann, Karen P.
    Natkunam, Yasodha
    Boise, Lawrence H.
    Saavedra, Harold I.
    Lossos, Izidore S.
    Bernal-Mizrachi, Leon
    INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (10) : 2341 - 2351
  • [34] CD30 activates both the canonical and alternative NF-κB pathways in anaplastic large cell lymphoma cells
    Wright, Casey W.
    Rumble, Julie M.
    Duckett, Colin S.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (14) : 10252 - 10262
  • [35] Puffing the 'Activate' in Activated B Cell-like Diffuse Large B Cell Lymphoma: A Role for the Noncanonical NF-κB Pathway
    Koff, Jean L.
    Guo, Xiangxue
    Ramachandiran, Sampath
    Switchenko, Jeffrey M.
    Mosunjac, Marina B.
    Neill, Stewart G.
    Mann, Karen
    Bagirov, Mahir
    Flowers, Christopher R.
    Lossos, Izidore S.
    Natkunam, Yaso
    Kowalski, Jeanne
    Bernal-Mizrachi, Leon
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 : S143 - S143
  • [36] Conditional survival of patients with diffuse large B-cell lymphoma.
    Moller, MB
    Pedersen, NT
    Christensen, BE
    BLOOD, 2005, 106 (11) : 542A - 542A
  • [37] CARD11 as an oncogene in diffuse large B cell lymphoma.
    Lenz, Georg
    Davis, R. Eric
    Ngo, Vu N.
    Lam, Lloyd T.
    George, Thaddeus
    Wright, George W.
    Dave, Sandeep S.
    Zhao, Hong
    Xu, Weihong
    Rosenwald, Andreas
    Muller-Hermelink, Hans-Konrad
    Gascoyne, Randy D.
    Connors, Joseph M.
    Campo, Elias
    Jaffe, Elaine S.
    Delabie, Jan
    Smeland, Eriend B.
    Rimsza, Lisa
    Fisher, Richard I.
    Chan, Wing C.
    Staudt, Louis M.
    BLOOD, 2007, 110 (11) : 213A - 213A
  • [38] Spectral and banded karyotype in 16 diffuse large B cell lymphoma.
    Terre, C
    Radford-Weiss, I
    Bastaraud, S
    Castaigne, S
    Romana, SP
    Bastard, C
    BLOOD, 2000, 96 (11) : 162B - 163B
  • [39] Carcinoma erysipelatoides associated with diffuse large B-cell lymphoma.
    Khan, B. Q.
    Gandhi, M.
    Edmonds, H.
    Ahmad, K.
    Rasberry, R. D.
    Corbett, C. E.
    Jakkola, A. F.
    Carbone, L. C.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (01) : S313 - S313
  • [40] Rituximab plus CHOP for diffuse large-B-cell lymphoma.
    Akhtar, S
    Maghfoor, I
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (23): : 1830 - 1831
12345